Dr. Yevgeny Azrieli, MD

Dr. Azrieli practices at Columbia University Irving Medical Center in New York, New York.

Dr. Azrieli's NPI, 1669411633, was assigned on June 5, 2006. Dr. Azrieli graduated from Icahn School Of Medicine At Mount Sinai in 1996. Dr. Azrieli holds New York license 208980.

Dr. Azrieli's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 305-4920.

Dr. Azrieli's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Azrieli is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Azrieli to 1 more hospital, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Azrieli practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Azrieli's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Azrieli is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Azrieli's licenses on file in 3 states: New York, Florida and New Jersey.

Dmand AI lists alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain, hereditary polyneuropathy and lower back pain among the conditions Dr. Azrieli treats.

CMS data shows 1,143 Medicare services from Dr. Azrieli across 11 procedure codes in 2024, for 416 Medicare patients. Medicare paid $130,531 for them. Every service was in an office.

CMS counts 416 Medicare patients who saw Dr. Azrieli in 2024. The largest group is 75 to 84, with 206 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Azrieli's median patient age at 58, with 65% women.

In 2024, Dr. Azrieli wrote 1,782 Medicare Part D claims for 294 patients. 93% of them were for generic drugs. CMS names the drug for 1,522 of them, across 35 drugs with 11 or more claims each, at $66,219 in total drug cost. In 2023, CMS named 1,530 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Azrieli for performance year 2024, reported through an alternative payment model (APM). Dr. Azrieli accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Azrieli as offering telehealth.

Dmand AI links 3 papers to Dr. Azrieli. Dr. Azrieli's most frequent co-authors are Ji Y. Chong, MD, Clifton L. Gooch, MD and Richard K. Lee, MD.

CMS Open Payments shows 3 general payments to Dr. Azrieli from 1 drug or device company from 2016 to 2017. Education make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $2.

Dr. Azrieli graduated from Icahn School Of Medicine At Mount Sinai in 1996. Dr. Azrieli is a member of AAN.

Dr. Azrieli is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.